Love shack Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Love shack

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Grandk who started this subject	12/28/2000 11:12:20 AM
From: Grandk	of 322

US Warburg asks everyone to buy more of their JNJ shares. JNJ breaking out to new year highs here. Almost everyone is in now. I expect a strong sell off to ensue within the next week that takes JNJ below 100. UBS Warburg Reiterates J&J As Strong Buy NEW YORK (Reuters) - UBS Warburg on Thursday said it reiterated a strong buy rating on diversified health care giant Johnson & Johnson (NYSE:JNJ - news). It also retained its 12-month target price of $115 on J&J stock. Analyst David Lothson said that 4 cents per share charge is to be taken from the company's net income in the fourth quarter because of J&J's acquisition of Atrionix Inc., a company that develops a system to treat heart disorder atrial fibrillation. J&J on Wednesday said it had completed the acquisition with Atrionix in an all-cash deal valued at $62.8 million. J&J shares closed down at $103 on Wednesday on the New York Stock Exchange (news - web sites). The stock price has a 52-week range between $66-3/16 and $104-3/4.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next